Oppenheimer Increases Addus HomeCare (NASDAQ:ADUS) Price Target to $150.00

Addus HomeCare (NASDAQ:ADUS) had its price objective raised by Oppenheimer from $145.00 to $150.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an outperform rating on the stock.

Other analysts also recently issued reports about the stock. KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Stephens increased their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Friday. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $134.22.

Addus HomeCare Stock Performance

ADUS stock opened at $130.62 on Friday. The firm has a market capitalization of $2.37 billion, a price-to-earnings ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00. The firm has a 50 day moving average price of $126.10 and a 200-day moving average price of $127.09. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same period in the previous year, the company posted $1.03 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 in the last ninety days. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds have recently modified their holdings of ADUS. Wasatch Advisors LP raised its holdings in Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares during the period. Point72 Asset Management L.P. increased its position in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. State Street Corp raised its stake in shares of Addus HomeCare by 4.4% in the third quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after buying an additional 27,990 shares during the period. Principal Financial Group Inc. lifted its position in shares of Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares in the last quarter. Finally, WCM Investment Management LLC grew its stake in shares of Addus HomeCare by 2.9% during the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock valued at $65,250,000 after acquiring an additional 13,938 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.